Joshua R. Korzenik

Gastroenterology, Brigham and Women’s Hospital, Boston, United States

CHARACTERISTICS OF PATIENTS WITH DURABLE USE OF INFLIXIMAB FOR > 5 YEARS
2012-01-01
English, Poster, Clinical aspects, Crohn’s disease, Medical management, Ulcerative colitis, Colon, Small intestine, 'IBD-ology', 2012
FACTORS ASSOCIATED WITH DURABLE RESPONSE TO INFLIXIMAB 5 YEARS AND BEYOND: A MULTI CENTER INTERNATIONAL COHORT
2013-01-01
English, Medical management, Inflammatory bowel disease, Abstract, 'IBD-ology', 2013